Suchergebnisse - "Xu, Qiding"

PubPharm (2)

1

AHNAK2 Promotes the Progression of Differentiated Thyroid Cancer through PI3K/AKT Signaling Pathway

enthalten in: Current cancer drug targets | 2024

von Xu, M. | Wen, J. | Xu, Q. | +4

2

SPTBN2 Promotes the Progression of Thyroid Cancer by Accelerating G1/S Transition and Inhibiting Apoptosis

enthalten in: Disease markers | 2022

von Zhou, X. | Lin, L. | Qi, Y. | +4

1
[1]